Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam benzenesulfonate for anesthesia induction in elderly hip replacement patients
ChiCTR2400086745Phase 4Not yet recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in None (2 arms), sponsored by The Second Xiangya Hospital. Primary endpoints: Plasma concentration of remimazolam at each time point, Pharmacokinetic parameters and 2 more. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2400086745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086745.